… HPV vaccination is likely to be beneficial to sexually active women due to their continuous
risk of acquiring new HPV … show that the HPV-16/18 AS04-adjuvanted vaccine is safe and …

… This section outlines the elements of the communication planning process discussed in the
last section and identifies key considerations for the introduction of HPV vaccine. The section …

… Programmatic feasibility is one key consideration of the World Health Organization's (WHO)
recommendation that routine HPV vaccination be included in national immunization …

… The complex discussion regarding the HPV single-dose vaccine schedule highlights the need
for … contexts influence decisions regarding the HPV vaccine single-dose recommendation. …

… to the consideration of vaccination of mid-adult women. This review summarizes HPV vaccine
studies in this age group, reviews the epidemiology and natural history of HPV infection, …

… We outline the objectives of male HPV vaccine effectiveness monitoring, identify the key
challenges to be addressed and consider possible options for such surveillance programs. …

… the available evidence and considerations in SCDM for HPV vaccination in midadults. The …
HPV vaccination in midadults; (2) describe the clinical rationale for midadult HPV vaccination; …

… –effectiveness of mass HPV vaccination programs in the context … Decisions following such
considerations may ultimately … and surveillance surrounding HPV vaccination will be essential …

… of cost-effectiveness considerations, we find a strong case to support universal HPV vaccination
of girls that is free at the point of use and, where feasible, to extend vaccination to boys …

… exposed to HPV, consideration should be … of HPV vaccination impact over the last 13
years. Looking to the future, ongoing and emerging challenges in the evaluation of HPV vaccine …